News from AGA
News from AGA
Impact of the AGA Research Foundation
News from AGA
VIDEO: Vedolizumab may benefit Crohn’s patients who fail anti-TNF therapy
Key clinical point: Vedolizumab seems to take longer than 6 weeks to work in patients with moderately to severely active Crohn’s disease. Major...